Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferdinando Clarelli

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Frontiers in Genetics|January 20, 2022
Contribution of Rare and Low-Frequency Variants to Multiple Sclerosis Susceptibility in the Italian Continental PopulationFerdinando Clarelli, Nadia Barizzone, Eleonora Mangano, et al.
Journal of Neurology|September 12, 2024
Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association studyFerdinando Clarelli, Andrea Corona, Kimmo Pääkkönen, et al.
Journal of Neurology|May 27, 2025
Correction: Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association studyFerdinando Clarelli, Andrea Corona, Kimmo Pääkkönen, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|August 6, 2021
Genomic and functional evaluation of TNFSF14 in multiple sclerosis susceptibilityMiriam Zuccalà, Nadia Barizzone, Elena Boggio, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 22, 2019
A pharmacogenetic study implicates <i>NINJ2</i> in the response to Interferon-β in multiple sclerosisSilvia Peroni, Melissa Sorosina, Sunny Malhotra, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 3, 2026
Pharmacogenomics of response to interferon-beta and glatiramer acetate in Multiple Sclerosis: A multi-centric studyAndrea Corona, Ferdinando Clarelli, Kimmo Pääkkönen, et al.
Genes|October 23, 2021
An Investigation of the Role of Common and Rare Variants in a Large Italian Multiplex Family of Multiple Sclerosis PatientsNadia Barizzone, Rachele Cagliani, Chiara Basagni, et al.
Genes|December 23, 2022
A Whole-Genome Sequencing Study Implicates GRAMD1B in Multiple Sclerosis SusceptibilityFederica Esposito, Ana Maria Osiceanu, Melissa Sorosina, et al.
Journal of Neurology|June 25, 2022
Correction to: A multi-step genomic approach prioritized TBKBP1 gene as relevant for multiple sclerosis susceptibilityMelissa Sorosina, Nadia Barizzone, Ferdinando Clarelli, et al.
Journal of Neurology|May 11, 2022
A multi-step genomic approach prioritized TBKBP1 gene as relevant for multiple sclerosis susceptibilityMelissa Sorosina, Nadia Barizzone, Ferdinando Clarelli, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Frontiers in Genetics|January 20, 2022
Contribution of Rare and Low-Frequency Variants to Multiple Sclerosis Susceptibility in the Italian Continental PopulationFerdinando Clarelli, Nadia Barizzone, Eleonora Mangano, et al.
Journal of Neurology|September 12, 2024
Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association studyFerdinando Clarelli, Andrea Corona, Kimmo Pääkkönen, et al.
Journal of Neurology|May 27, 2025
Correction: Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association studyFerdinando Clarelli, Andrea Corona, Kimmo Pääkkönen, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|August 6, 2021
Genomic and functional evaluation of TNFSF14 in multiple sclerosis susceptibilityMiriam Zuccalà, Nadia Barizzone, Elena Boggio, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 22, 2019
A pharmacogenetic study implicates <i>NINJ2</i> in the response to Interferon-β in multiple sclerosisSilvia Peroni, Melissa Sorosina, Sunny Malhotra, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 3, 2026
Pharmacogenomics of response to interferon-beta and glatiramer acetate in Multiple Sclerosis: A multi-centric studyAndrea Corona, Ferdinando Clarelli, Kimmo Pääkkönen, et al.
Genes|October 23, 2021
An Investigation of the Role of Common and Rare Variants in a Large Italian Multiplex Family of Multiple Sclerosis PatientsNadia Barizzone, Rachele Cagliani, Chiara Basagni, et al.
Genes|December 23, 2022
A Whole-Genome Sequencing Study Implicates GRAMD1B in Multiple Sclerosis SusceptibilityFederica Esposito, Ana Maria Osiceanu, Melissa Sorosina, et al.
Journal of Neurology|June 25, 2022
Correction to: A multi-step genomic approach prioritized TBKBP1 gene as relevant for multiple sclerosis susceptibilityMelissa Sorosina, Nadia Barizzone, Ferdinando Clarelli, et al.
Journal of Neurology|May 11, 2022
A multi-step genomic approach prioritized TBKBP1 gene as relevant for multiple sclerosis susceptibilityMelissa Sorosina, Nadia Barizzone, Ferdinando Clarelli, et al.
Pageof 5